Brief: Guardion Health Sciences Names David Evans As Interim President And Interim CEO
15/06/2020 21:22
June 15 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* GUARDION HEALTH SCIENCES NAMES DR. DAVID EVANS AS INTERIM
PRESIDENT AND INTERIM CHIEF EXECUTIVE OFFICER
* GUARDION HEALTH SCIENCES INC - EVANS SUCCEEDS MICHAEL
FAVISH
* GUARDION HEALTH SCIENCES INC - BOARD CONDUCTING EXTENSIVE
SEARCH
TO IDENTIFY NEXT CEO
Source text for Eikon: ID:nGNX19G5XG
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview